Dr. Joshua Kaleb Kolmetz, MD

Dr. Kolmetz practices at Main Street Medical Center - Laboratory in Crestview, Florida.

Dr. Kolmetz's NPI, 1699862599, was assigned on October 10, 2006. Dr. Kolmetz graduated from University Of Florida College Of Medicine in 2004. Dr. Kolmetz holds Florida license ME97211.

Dr. Kolmetz's primary practice is Main Street Medical Center - Laboratory, at 369 N Main St, Crestview, FL 32536. The practice phone is (850) 398-6963.

Dr. Kolmetz's primary practice is Main Street Medical Center - Laboratory in Crestview, Florida. Dr. Kolmetz is also affiliated with North Okaloosa Medical Center. The medical group on file is Main Street Medical Center. Dmand AI also links Dr. Kolmetz to 4 more hospitals, 4 home health agencies and 1 group practice or clinic, each named with a free account. Dr. Kolmetz's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kolmetz practices, 11 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kolmetz's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kolmetz is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kolmetz's licenses on file in 15 states: Florida, South Dakota, Arizona, Colorado, Delaware, Montana, New Hampshire, Nevada, Ohio, Georgia, Hawaii, Iowa, Idaho, Illinois and Kansas.

Dmand AI lists acid reflux, acute gastroduodenitis, acute kidney failure, acute mini-stroke (TIA), acute sinusitis, acute skin infection, ADHD and alcohol use disorders among the conditions Dr. Kolmetz treats.

CMS data shows 12,334 Medicare services from Dr. Kolmetz across 29 procedure codes in 2024, for 979 Medicare patients. Medicare paid $608,836 for them. Every service was in an office.

CMS counts 979 Medicare patients who saw Dr. Kolmetz in 2024. The largest group is 65 to 74, with 472 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kolmetz's median patient age at 63, with 58% women.

In 2024, Dr. Kolmetz wrote 8,941 Medicare Part D claims for 899 patients. 86% of them were for generic drugs. CMS names the drug for 8,159 of them, across 139 drugs with 11 or more claims each, at $776,359 in total drug cost. In 2023, CMS named 8,048 claims across 146 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kolmetz for performance year 2024, reported as part of a group. Dr. Kolmetz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1,297 general payments to Dr. Kolmetz from 65 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novo Nordisk Inc paid the most, $3,823.

Dmand AI lists 1 award for Dr. Kolmetz, most recently CMS Stage 1 EHR in 2013.

Dr. Kolmetz graduated from University Of Florida College Of Medicine in 2004.

Dr. Kolmetz is in network with 14 carriers, including Excellus BlueCross BlueShield, Aetna and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.